What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Disease
Mark Walterfang mostly deals with Psychosis, Neuroscience, Schizophrenia, White matter and Disease.
His studies deal with areas such as Acute intermittent porphyria, Temporal lobe, Atrophy and Neuropsychiatry as well as Psychosis.
Mark Walterfang works mostly in the field of Neuroscience, limiting it down to topics relating to Audiology and, in certain cases, Limbic system and Insular cortex, as a part of the same area of interest.
His Schizophrenia research is within the category of Psychiatry.
The White matter study which covers Neuroimaging that intersects with Substance abuse.
His Disease study integrates concerns from other disciplines, such as Pediatrics and MEDLINE.
His most cited work include:
- Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. (344 citations)
- Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. (300 citations)
- Hashimoto's encephalopathy : epidemiology, pathogenesis and management. (171 citations)
What are the main themes of his work throughout his whole career to date?
Psychiatry, Neuroscience, Dementia, Psychosis and Frontotemporal dementia are his primary areas of study.
The study incorporates disciplines such as Disease and Neurological disorder in addition to Psychiatry.
He focuses mostly in the field of Disease, narrowing it down to matters related to Ataxia and, in some cases, Miglustat.
His Neuroscience study frequently intersects with other fields, such as White matter.
His work investigates the relationship between Dementia and topics such as Pediatrics that intersect with problems in Dysphagia.
His study focuses on the intersection of Psychosis and fields such as Schizophrenia with connections in the field of Bipolar disorder.
He most often published in these fields:
- Psychiatry (40.22%)
- Neuroscience (31.56%)
- Dementia (29.33%)
What were the highlights of his more recent work (between 2018-2021)?
- Dementia (29.33%)
- Depression (13.41%)
- Cognition (23.74%)
In recent papers he was focusing on the following fields of study:
Mark Walterfang mainly focuses on Dementia, Depression, Cognition, Neuroscience and Frontotemporal dementia.
His Dementia research includes themes of Biomarker, Frontal lobe, Gerontology and Neuropsychiatry.
Depression is a subfield of Psychiatry that he investigates.
His work in Cognition addresses subjects such as Audiology, which are connected to disciplines such as Visual search, Fixation, Cognitive load and Eye movement.
His research in Neuroscience intersects with topics in Psychosis and Parkinson's disease.
His research in Frontotemporal dementia tackles topics such as Yod which are related to areas like Pediatrics and Cohort study.
Between 2018 and 2021, his most popular works were:
- Systematic review of psychiatric signs in Niemann-Pick disease type C. (18 citations)
- Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale – Depression subscale scores: An individual participant data meta-analysis of 73 primary studies (13 citations)
- Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale – Depression subscale scores: An individual participant data meta-analysis of 73 primary studies (13 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Disease
His primary scientific interests are in Internal medicine, Cognition, Depression, Frontotemporal dementia and Dementia.
Many of his research projects under Cognition are closely connected to Phenylalanine hydroxylase with Phenylalanine hydroxylase, tying the diverse disciplines of science together.
His Frontotemporal dementia research is multidisciplinary, relying on both Yod, Time to diagnosis, Pediatrics and Neuropsychiatry.
His Dementia research is multidisciplinary, incorporating elements of Alzheimer's disease, Biomarker and Bioinformatics.
The concepts of his Disease study are interwoven with issues in Ataxia, Psychosis, Mood disorders and Schizophrenia.
As a part of the same scientific family, he mostly works in the field of Psychosis, focusing on Cannabis and, on occasion, Neuroscience.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
